Appointment of Nominated Adviser and Broker
Surgical Innovations Group plc
("Surgical Innovations" or "the "Company")
Appointment of Nominated Adviser and Broker
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.
For further information contact:
|
Surgical Innovations Group Plc |
|
|
Nigel Rogers, Executive Chairman |
Tel: +44 (0)113 230 7597 |
|
Melanie Ross, COO and CFO |
|
|
|
|
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: +44 (0)20 7933 8780 or si@walbrookpr.com |
|
Paul McManus |
Mob: +44 (0)7980 541 893 |
|
Lianne Cawthorne |
Mob: +44 (0)7584 391 303 |
|
|
|
|
N+1 Singer - Nominated Adviser and Broker |
+44 (0)20 7496 3000 |
|
Richard Lindley |
|
|
Rachel Hayes |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
COMPANIES COVERED:
Latest directors dealings
- 1 day ago FRP Advisory Group
- 1 day ago Marks Electrical Group
- 1 day ago CLS Holdings
- 1 day ago QinetiQ Group
- 1 day ago Spectris